Lisinopril indications and usage: Difference between revisions

Jump to navigation Jump to search
No edit summary
 
Line 1: Line 1:
__NOTOC__
#REDIRECT [[Lisinopril#Adult Indications and Dosage]]
{{Lisinopril}}
{{CMG}}; {{AE}} {{AM}}
 
==Indications and Usage==
 
====Hypertension====
 
Lisinopril tablets are indicated for the treatment of [[hypertension]]. They may be used alone as initial therapy or concomitantly with other classes of antihypertensive agents.
 
====Heart Failure====
 
Lisinopril tablets are indicated as adjunctive therapy in the management of [[heart failure]] in patients who are not responding adequately to [[diuretics]] and [[digitalis]].
 
====Acute Myocardial Infarction====
 
Lisinopril tablets are indicated for the treatment of hemodynamically stable patients within 24 hours of [[acute myocardial infarction]], to improve survival. Patients should receive, as appropriate, the standard recommended treatments such as [[thrombolytics]], [[aspirin]], and [[beta-blockers]].
 
In using lisinopril tablets, consideration should be given to the fact that another angiotensin converting enzyme inhibitor, [[captopril]], has caused [[agranulocytosis]], particularly in patients with renal impairment or [[collagen vascular disease]], and that available data are insufficient to show that lisinopril tablets do not have a similar risk.
 
In considering the use of lisinopril tablets, it should be noted that in controlled trials ACE inhibitors have an effect on blood pressure that is less in black patients than in non-blacks. In addition, ACE inhibitors have been associated with a higher rate of [[angioedema]] in black than in nonblack patients.<ref name="dailymed.nlm.nih.gov">{{Cite web  | last =  | first =  | title = LISINOPRIL (LISINOPRIL) TABLET [LEK PHARMACEUTICALS] | url = http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=27ccb2f4-abf8-4825-9b05-0bb367b4ac07 | publisher =  | date =  | accessdate = }}</ref>
 
==References==
{{Reflist}}
 
{{FDA}}
 
[[Category:Cardiovascular Drugs]]
[[Category:Drugs]]

Latest revision as of 19:55, 21 July 2014